Sign in
Taking people in United StatesNo phase

Screens people with heart disease, obesity or diabetes for future clinical trials

Surveys adults with heart, weight or blood sugar conditions to check trial eligibility.

Key facts

Who runs it
Brooklyn Clinical Research
Where
Brooklyn, United StatesSee the site
Trial code
Registry title
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
Status
Recruiting
People taking part
10,000 people, planned
Started
30 May 2024
Expected to end
17 Apr 2029
Type of study
Observational
Treatments tested
  • Blood work
Record updated
11 June 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

This is a survey study at one site. It checks whether adults can go on to screening for other industry-sponsored trials on heart disease, obesity, prediabetes, type 2 diabetes or metabolic syndrome.

Age
18 years or older
Sex
All sexes can join

Main reasons for not taking part

  • Pregnant, breast-feeding or planning to become pregnant
  • Moderate or severe substance use disorder within 90 days before screening
  • A clinically significant illness that, in the investigator's opinion, may affect safety or the study results
  • Any condition that, in the investigator's opinion, makes the person unsuitable for the study
  • Works for Swift Clinical Research Group, Inc. or its subsidiaries, or is a first-degree relative of an employee

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed
  • Participant is at least 18 years old

Who cannot take part

  • Moderate or severe substance use disorder within 90 days prior to screen
  • History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results
  • Any condition that in the investigator's opinion makes a participant unsuitable for the study
  • Participant is pregnant, breast-feeding, or planning to become pregnant
  • Currently employed by Swift Clinical Research Group, Inc. or any of its subsidiaries, including Brooklyn Clinical Research, or a first-degree relative of an employee

Where in United States

  • Brooklyn Clinical ResearchBrooklyn, United StatesContact: Ammara Mushtaq, MDTaking people

About the trial

What the trial wants to find out

SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, blood draws, and urine pregnancy tests. A doctor will review medical history with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians and pharmacies to determine eligibility for clinical trials.

Treatments tested

  • Blood work

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility (SWIFT-CORE-101)
Plain-language title
Screens people with heart disease, obesity or diabetes for future clinical trialsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
11 June 2024